Their results show correlation between LCN2 and progressive skin sclerosis as well as pulmonary vascular involvement that leads to pulmonary arterial hypertension in SSc. Furthermore, [41] demonstrate increased expression of LCN2, correlated with tubulointerstitial fibrosis and tubular cell injury in patients with Chronic Kidney Disease. This evidence concerns the gene LCN2 and chronic kidney disease.